Kodu・Aktsiate loetelu・Elevance Health Inc

Elevance Health Inc

Suletud

SektorTervishoid

400.3 0.73

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

395.1

Max

402.19

Põhinäitajad
By Trading Economics
Sissetulek	-306M 1.5B
Müük	293M 50B
P/E Sektori keskmine	17.42 57.002
Aktsiakasum	7.45
Dividenditootlus	1.74
Kasumimarginaal	2.881
Töötajad	96,129
EBITDA	-670M 2.1B

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+12.24% upside

Dividendid
By Acuity
Dividenditootlus Sektori keskmine	1.74% 2.22%
Järgmine tulemuste avaldamine	20. okt 2026
Järgmine dividendimakse kuupäev	25. sept 2026
Järgmine aktsia dividendi kuupäev (ex-date)	10. sept 2026

Turustatistika
By TradingEconomics
Turukapital	-4.1B 86B
Eelmine avamishind	399.57
Eelmine sulgemishind	400.3

Uudiste sentiment

By Acuity

51%

49%

273 / 340 Pingereas Healthcare

Elevance Health Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

13. aug 2026, 19:36 UTC

News

Elevance Health Inc shares declined amid rising jobless claims, reflecting broader market trends. The stock remains within its one-month trading range.

12. aug 2026, 22:06 UTC

Shares of Elevance Health Inc. declined in after-market trading, reflecting unusual activity amid broader market dynamics following the recent Consumer Price Index report.

11. aug 2026, 19:26 UTC

Social Media

Elevance Health shares are lower amid investor concerns from first-quarter earnings reports. Social media discussions suggest the company may be undervalued despite challenges.

6. aug 2026, 19:16 UTC

Social Media

Elevance Health Inc shares are lower today, despite social media suggesting a potential price target of $422 and notable call option activity.

5. aug 2026, 22:51 UTC

Elevance Health Inc shares are lower in after-market hours, with no specific news identified to explain the movement. Broader market concerns may be influencing sentiment.

4. aug 2026, 19:56 UTC

Elevance Health Inc shares are lower today, continuing a decline since Monday. The stock trades near its one-month low amid broader market strength.

3. aug 2026, 19:26 UTC

News

Elevance Health Inc enhances its cancer care model amid market strength. Shares are higher today, reflecting positive momentum since Friday's close.

31. juuli 2026, 19:46 UTC

News

Elevance Health updated its fiscal year 2026 EPS guidance to 27.000, above the consensus of 26.890, as shares trade higher today.

30. juuli 2026, 20:09 UTC

Elevance Health Inc. shares are near unchanged amid mixed economic signals, including lower-than-expected U.S. GDP growth and rising jobless claims.

29. juuli 2026, 20:09 UTC

News

Elevance Health Inc shares are lower amid ongoing margin pressures, despite management's projection of adjusted EPS of at least $27 for 2026.

28. juuli 2026, 19:03 UTC

Elevance Health shares are higher today, rebounding from an earlier dip. No specific news was identified to explain the price movement.

27. juuli 2026, 21:56 UTC

Elevance Health Inc shares are lower in after-market hours, with no specific news identified. The stock remains near the lower end of its one-month trading range.

23. juuli 2026, 10:36 UTC

Elevance Health Inc shares are lower in pre-market hours, following a decline on Wednesday and amid broader market weakness in major tech companies.

22. juuli 2026, 22:01 UTC

Elevance Health Inc shares are lower in after-market trading, reflecting a decline from opening levels and positioning below the 20-day moving average.

21. juuli 2026, 16:36 UTC

Social Media

Elevance Health Inc shares are among the top gainers in the S&P 500 today, reflecting favorable market dynamics despite no specific catalysts identified.

20. juuli 2026, 23:02 UTC

Elevance Health Inc's shares are lower in after-market hours, reflecting a decline since Monday's close. The stock remains below its 20-day moving average.

Võrdlus sarnastega

Hinnamuutus

Elevance Health Inc Prognoos

Hinnasiht

By TipRanks

12.24% tõus

12 kuu keskmine prognoos

Keskmine 449.33 USD 12.24%

Kõrge 498 USD

Madal 393 USD

Põhineb 19 Wall Streeti analüütiku instrumendi Elevance Health Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

19 ratings

Osta

Hoia

Müü

Põhineb 19 analüütiku instrumendi Elevance Health Inc aktsia reitingul - viimase 3 kuu andmed.

Sentiment

By Acuity

273 / 340 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Elevance Health Inc

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.